DK2909314T3 - Behandling af smerte med amnion afledte vedhæftende celler - Google Patents

Behandling af smerte med amnion afledte vedhæftende celler Download PDF

Info

Publication number
DK2909314T3
DK2909314T3 DK13846458.1T DK13846458T DK2909314T3 DK 2909314 T3 DK2909314 T3 DK 2909314T3 DK 13846458 T DK13846458 T DK 13846458T DK 2909314 T3 DK2909314 T3 DK 2909314T3
Authority
DK
Denmark
Prior art keywords
pain
treatment
adherent cells
derived adherent
amnion derived
Prior art date
Application number
DK13846458.1T
Other languages
Danish (da)
English (en)
Inventor
Uri Herzberg
Robert J Hariri
Jodi P Gurney
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Application granted granted Critical
Publication of DK2909314T3 publication Critical patent/DK2909314T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/51Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK13846458.1T 2012-10-19 2013-10-18 Behandling af smerte med amnion afledte vedhæftende celler DK2909314T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261716091P 2012-10-19 2012-10-19
US201361783752P 2013-03-14 2013-03-14
PCT/US2013/065653 WO2014063035A2 (en) 2012-10-19 2013-10-18 Treatment of pain using amnion derived adherent cells

Publications (1)

Publication Number Publication Date
DK2909314T3 true DK2909314T3 (da) 2021-03-08

Family

ID=50488901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13846458.1T DK2909314T3 (da) 2012-10-19 2013-10-18 Behandling af smerte med amnion afledte vedhæftende celler

Country Status (6)

Country Link
US (1) US20160166618A1 (enExample)
EP (1) EP2909314B1 (enExample)
JP (4) JP2015536326A (enExample)
CA (1) CA2888772A1 (enExample)
DK (1) DK2909314T3 (enExample)
WO (1) WO2014063035A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016006270A (es) 2013-11-15 2016-09-07 Anthrogenesis Corp Composiciones que comprenden células perfundidas de placenta humana, subpoblaciones de las mismas y sus usos.
CN113679741B (zh) * 2021-09-13 2023-09-19 北京大学第一医院 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210379B1 (en) 1999-04-16 2007-03-21 Wm. MARSH RICE UNIVERSITY Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
ES2420354T3 (es) * 2000-07-07 2013-08-23 Spectrum Pharmaceuticals, Inc. Métodos para el tratamiento de neuropatía periférica inducida por una enfermedad y afecciones relacionadas
NZ527849A (en) 2001-02-14 2006-09-29 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
DK2471904T3 (en) 2005-12-29 2019-02-18 Celularity Inc Placenta stem cell populations
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
CA2743566C (en) * 2008-11-19 2021-11-09 Anthrogenesis Corporation Amnion derived adherent cells
AU2010322808B9 (en) * 2009-11-30 2014-08-07 Pluri Biotech Ltd Adherent cells from placenta and use of same in disease treatment
KR20140022776A (ko) * 2010-11-16 2014-02-25 지우세페 마리네오 아편제 및 통상적인 전기 진통에 내성이 있는 신경병증 통증, 종양 통증 및 소아 통증을 신속히 억제하기 위한 장치 및 방법
AU2011343736A1 (en) * 2010-12-17 2013-05-02 Anthrogenesis Corporation Treatment of immune-related diseases and disorders using amnion derived adherent cells
AR084753A1 (es) 2010-12-30 2013-06-05 Anthrogenesis Corp Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)

Also Published As

Publication number Publication date
JP2020180128A (ja) 2020-11-05
JP7315755B2 (ja) 2023-07-26
WO2014063035A2 (en) 2014-04-24
CA2888772A1 (en) 2015-04-24
WO2014063035A3 (en) 2014-06-19
EP2909314A4 (en) 2016-10-12
HK1214299A1 (en) 2016-07-22
EP2909314A2 (en) 2015-08-26
JP2015536326A (ja) 2015-12-21
EP2909314B1 (en) 2020-12-02
US20160166618A1 (en) 2016-06-16
JP2022130406A (ja) 2022-09-06
JP2018188456A (ja) 2018-11-29

Similar Documents

Publication Publication Date Title
DK2931752T3 (da) Behandling af cd47+ sygdomsceller med sirp-alpha-fc-fusioner
DK2890836T3 (da) Fremgangsmåder i forbindelse med modulatorer af eukaryotiske celler
DK3501549T3 (da) Behandling af amd med aav sflt-1
EP3744725C0 (en) DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR THEIR PRECURSORS
FR2995619B3 (fr) Structure de fixation de robinet
IL240252B (en) Solid substrates for promoting cell and tissue growth
IL228701A0 (en) Bcma-based stratification and therapy for multiple myeloma patients
BR112013022813A2 (pt) diaminocarbonitrila pirimidinas e diaminocarboxamida substituída, composições das mesmas e métodos de tratamento com as mesmas
HRP20160862T8 (hr) Sklop posude i pridruženi postupak
LT2885010T (lt) Tautopatijos gydymo būdai
DK3281607T3 (da) Implanterbar protese med acellulære vævsvedhæftninger.
IL232262A0 (en) Therapeutic agents and uses thereof
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
DK2818241T3 (da) Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur
DK2925889T3 (da) Diagnostiske markører til behandling af celleproliferationsforstyrrelser med telomeraseinhibitorer
EP2731440A4 (en) RADIATION LESSON TREATMENT USING ADHESENT CELLS DERIVED FROM AMNIOS
EP2696949A4 (en) BINDING
DK2903432T3 (da) Fremgangsmåde til behandling af sædceller til kønsortering
EP2780012A4 (en) Methods of treatment with deferiprone
DK3446565T3 (da) Fremgangsmåder til behandling af antipsykotika-induceret vægtøgning
EP2543396A4 (en) ARTIFICIAL SKIN
DK2830645T3 (da) Neuregulin til anvendelse i behandling af perifær nervelæsion
EP2810665A4 (en) bio-implant
DK2997129T3 (da) Elektronisk ekspression af indadensretteren i cardiocytter, der er afledt fra menneskeligt inducerede pluripotente stamceller
DK3132684T3 (da) Behandling af fiskepopulationer med lufenuron